Skip to content

Corteva

NYSE: CTVA · USD

Corteva revenue84

Quarterly and annual revenue from company filings.

Business drivers

Business lines and operating measures.

Corn · Seed revenue

Reported quarterly Corn · Seed revenue. Quarterly figures · USD

Corn · Seed revenue. Reported quarterly Corn · Seed revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 20262,868,000,000Filed Jul 31, 2026
Mar 31, 2026From Jan 1, 20262,373,000,000Filed May 6, 2026
Jun 30, 2025From Apr 1, 20252,961,000,000Filed Jul 31, 2026
Mar 31, 2025From Jan 1, 20252,069,000,000Filed May 6, 2026

Soybean · Seed revenue

Reported quarterly Soybean · Seed revenue. Quarterly figures · USD

Soybean · Seed revenue. Reported quarterly Soybean · Seed revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 20261,318,000,000Filed Jul 31, 2026
Mar 31, 2026From Jan 1, 2026306,000,000Filed May 6, 2026
Jun 30, 2025From Apr 1, 20251,257,000,000Filed Jul 31, 2026
Mar 31, 2025From Jan 1, 2025305,000,000Filed May 6, 2026

Herbicides · Crop Protection revenue

Reported quarterly Herbicides · Crop Protection revenue. Quarterly figures · USD

Herbicides · Crop Protection revenue. Reported quarterly Herbicides · Crop Protection revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 2026932,000,000Filed Jul 31, 2026
Mar 31, 2026From Jan 1, 20261,027,000,000Filed May 6, 2026
Jun 30, 2025From Apr 1, 2025995,000,000Filed Jul 31, 2026
Mar 31, 2025From Jan 1, 2025860,000,000Filed May 6, 2026

Independent series; they may overlap and do not form an additive breakdown.

  • Available observations cover only part of each year and provide no physical operating volumes.

Products & projects

Biologicals

ZORVEC™; ADAVELT™; INATREQ™; FORCIVO™; APROACH® PRIMA; VESSARYA®; APROACH® PREMIUM; APROACH POWER®; VIOVAN®; TALENDO™; VERBEN®; EQUATION PRO®; EQUATION CONTACT®; CURZATE™; TANOS®; BIM® MAX; FONTELIS™; ACANTO® PLUS; GALILEO®; UNIVOQ® Weed Control ARYLEX®; ENLIST® weed control system; ENLIST ONE™; RINSKOR™; KERB®; QUELEX™; BELKAR®; PACTO®; LOYANT™; GRAZONNEXT® HL; PAXEO®; RESICORE® REV; SPIDER®; COACT®; DURACOR®; GAPPER®; ELEVORE®; FULTIME® NXT; KYBER® PRO; LINEAR®; TORDONULTRA®-S; VERDICT® ULTRA Nitrogen Management INSTINCT®; N-SERVE® Nitrogen Stabilizer Biologicals STIMULATE™; UTRISHA™ N; BlueN™; and STARTER™ Other LANDVisor™ Key Raw Materials The key raw materials and supplies for the Crop Protection segment include chlorinated pyridines derivatives, specialty intermediates and technical grade active ingredients, chlorine, and seed treatments.

Filed · source for Biologicals

Vylor

As previously announced, on Tuesday, September 15, 2026, Corteva will host a live video webcast of its Investor Day, which will be divided into two parts: at 9:00 AM EDT, Corteva will introduce Vylor, its advanced seed and genetics business as a future standalone, public company.

Filed · source for Vylor

Revenue history

USD millions · Fiscal periods
Mar 31, 2019 through Jun 30, 2026

Quarterly data

Corteva quarterly financial data in USD millions. FY denotes the company's fiscal year. YTD covers reported quarters only.
Fiscal quarterEndedTotal revenueUSD millions
FY 2026 Q2Jun 30, 20266,379, +30.1% versus FY 2026 Q1
FY 2026 Q1Mar 31, 20264,905, +25.4% versus FY 2025 Q4
FY 2025 Q4Dec 31, 20253,910, +49.4% versus FY 2025 Q3
FY 2025 Q3Sep 30, 20252,618, −59.4% versus FY 2025 Q2
FY 2025 Q2Jun 30, 20256,456, +46.2% versus FY 2025 Q1
FY 2025 Q1Mar 31, 20254,417, +11.0% versus FY 2024 Q4
FY 2024 Q4Dec 31, 20243,978, +71.0% versus FY 2024 Q3
FY 2024 Q3Sep 30, 20242,326, −61.9% versus FY 2024 Q2
FY 2024 Q2Jun 30, 20246,112, +36.1% versus FY 2024 Q1
FY 2024 Q1Mar 31, 20244,492, +21.2% versus FY 2023 Q4
FY 2023 Q4Dec 31, 20233,707, +43.1% versus FY 2023 Q3
FY 2023 Q3Sep 30, 20232,590, −57.2% versus FY 2023 Q2
FY 2023 Q2Jun 30, 20236,045, +23.8% versus FY 2023 Q1
FY 2023 Q1Mar 31, 20234,884, +27.7% versus FY 2022 Q4
FY 2022 Q4Dec 31, 20223,825, +37.7% versus FY 2022 Q3
FY 2022 Q3Sep 30, 20222,777, −55.6% versus FY 2022 Q2
FY 2022 Q2Jun 30, 20226,252, +35.9% versus FY 2022 Q1
FY 2022 Q1Mar 31, 20224,601, +32.3% versus FY 2021 Q4
FY 2021 Q4Dec 31, 20213,479, +46.7% versus FY 2021 Q3
FY 2021 Q3Sep 30, 20212,371, −57.9% versus FY 2021 Q2
FY 2021 Q2Jun 30, 20215,627, +34.7% versus FY 2021 Q1
FY 2021 Q1Mar 31, 20214,178, +30.3% versus FY 2020 Q4
FY 2020 Q4Dec 31, 20203,207, +72.1% versus FY 2020 Q3
FY 2020 Q3Sep 30, 20201,863, −64.1% versus FY 2020 Q2
FY 2020 Q2Jun 30, 20205,191, +31.2% versus FY 2020 Q1
FY 2020 Q1Mar 31, 20203,956, +32.6% versus FY 2019 Q4
FY 2019 Q4Dec 31, 20192,983, +56.1% versus FY 2019 Q3
FY 2019 Q3Sep 30, 20191,911, −65.6% versus FY 2019 Q2
FY 2019 Q2Jun 30, 20195,556, −11.6% versus FY 2019 Q1
FY 2019 Q1Mar 31, 20196,288, Change unavailable versus FY 2018 Q4
Sources and definitions

Figures from official company filings and financial reports, in the reported currency. FY identifies the fiscal year; the end date identifies the calendar period. Last checked Oct 19, 2026.

Annual values come from annual filings. Historical quarters retain their reporting basis; rounding and reclassifications can make their sum differ from the annual figure. YTD sums the available fiscal quarters and compares the same quarters of the previous fiscal year.

Missing values are shown as unavailable. Fourth quarters use reported values where available, otherwise the annual amount less the matching nine-month amount.

Total revenue
Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported.
Annual and quarterly differences
  • FY 2019 · Total revenue: annual 13,846, quarter sum 16,738 USD millions.